ロード中...
Bortezomib treatment for severe refractory anti‐NMDA receptor encephalitis
OBJECTIVE: To evaluate the therapeutic potential of bortezomib, a proteasome inhibitor that target plasma cells, in order to revive stalled recovery in patients with anti‐N‐methyl‐d‐aspartate (NMDA) receptor encephalitis who remain bedridden even after aggressive immunotherapy. METHODS: We consecuti...
保存先:
| 出版年: | Ann Clin Transl Neurol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5945964/ https://ncbi.nlm.nih.gov/pubmed/29761122 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.557 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|